Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354614 · ClinicalTrials.gov registry record
Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by ResMed.
- Completed
- Registry status
- 81
- Enrollment target
NCT00354614 is a clinical trial that has completed, run by ResMed. The registered enrollment target is 81 participants.
The verdict
NCT00354614 has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The primary endpoints for this study are that the AL validation will 1) achieve a sensitivity of greater than 80% for AHI values greater than or equal to 15, and 2) demonstrate a correlation coefficient of r=0.75 indicating strong correlation between the AHI of diagnostic PSG and AL.
Interventions
- DEVICE ApneaLink Sleep Screener
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00354614
The ClinicalTrials.gov registry entry for NCT00354614 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ApneaLink Sleep Screener is the first listed.
NCT00354614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00354614 about?
NCT00354614 is a clinical study titled "Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)". The primary endpoints for this study are that the AL validation will 1) achieve a sensitivity of greater than 80% for AHI values greater than or equal to 15, and 2) demonstrate a correlation coefficient of r=0.75 indicating strong correlation between the AHI of diagnostic PSG and AL.
What is the current status of trial NCT00354614?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2006-06. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00354614?
The interventions under investigation include: ApneaLink Sleep Screener (DEVICE).
Who is sponsoring clinical trial NCT00354614?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.